428 Shares in Revvity, Inc. (NYSE:RVTY) Purchased by GAMMA Investing LLC

GAMMA Investing LLC acquired a new stake in shares of Revvity, Inc. (NYSE:RVTY) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 428 shares of the company’s stock, valued at approximately $46,000.

Other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. acquired a new position in Revvity in the third quarter valued at approximately $1,579,487,000. Ceredex Value Advisors LLC acquired a new position in shares of Revvity in the 4th quarter valued at $108,353,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new position in shares of Revvity during the 4th quarter worth $33,568,000. Boston Trust Walden Corp acquired a new stake in shares of Revvity during the 4th quarter worth about $25,154,000. Finally, KBC Group NV purchased a new stake in Revvity in the 3rd quarter valued at about $25,301,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on RVTY. Stifel Nicolaus lifted their price target on shares of Revvity from $95.00 to $110.00 and gave the company a “hold” rating in a research report on Friday, February 2nd. Barclays lifted their price objective on Revvity from $92.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, January 25th. Raymond James boosted their price objective on Revvity from $106.00 to $127.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. UBS Group cut Revvity from a “buy” rating to a “neutral” rating and raised their target price for the company from $105.00 to $125.00 in a report on Tuesday, January 16th. Finally, Robert W. Baird lifted their price objective on shares of Revvity from $126.00 to $127.00 and gave the company an “outperform” rating in a report on Tuesday. Six investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $118.17.

Insider Activity at Revvity

In other Revvity news, insider Prahlad R. Singh sold 21,217 shares of the firm’s stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the transaction, the insider now owns 92,801 shares of the company’s stock, valued at $9,677,288.28. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.60% of the stock is owned by corporate insiders.

Revvity Stock Performance

NYSE:RVTY opened at $100.61 on Friday. The firm has a market capitalization of $12.43 billion, a PE ratio of 83.15, a price-to-earnings-growth ratio of 2.67 and a beta of 1.09. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.23 and a quick ratio of 1.77. The business’s fifty day moving average price is $104.56 and its 200 day moving average price is $101.28. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $132.54.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Monday, April 29th. The company reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.04. Revvity had a return on equity of 7.37% and a net margin of 5.49%. The firm had revenue of $649.90 million during the quarter, compared to the consensus estimate of $646.83 million. During the same period in the prior year, the company posted $1.01 earnings per share. The firm’s quarterly revenue was down 3.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Revvity, Inc. will post 4.65 earnings per share for the current fiscal year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, July 19th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $0.28 annualized dividend and a yield of 0.28%. Revvity’s dividend payout ratio is currently 23.14%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.